Friedrich-Wilhelm Kreth
Overview
Explore the profile of Friedrich-Wilhelm Kreth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1242
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stoecklein V, Kellert L, Patzig M, Kupper C, Giese A, Ruf V, et al.
J Neurol
. 2020 Aug;
268(1):367-376.
PMID: 32813052
Objective: To evaluate the diagnostic accuracy and safety of extended stereotactic brain biopsy (ESBB) in a single center cohort with suspected primary angiitis of the central nervous system (PACNS). Methods:...
2.
Hubner M, Moellhoff N, Effinger D, Hinske C, Hirschberger S, Wu T, et al.
Neurooncol Adv
. 2020 Jul;
2(1):vdaa047.
PMID: 32642700
Background: Inflammation is an important driver of malignant glioma disease. Inflammatory mediators are not only produced by immune cells in the tumor microenvironment, but also by glioblastoma (GBM) cells themselves...
3.
Hubner M, Effinger D, Wu T, Strauss G, Pogoda K, Kreth F, et al.
Cancers (Basel)
. 2020 Feb;
12(2).
PMID: 32069807
Background: The recombinant IL-1 receptor antagonist anakinra-currently approved for the treatment of autoinflammatory diseases-blocks IL-1β-mediated inflammatory signaling. As inflammation is a major driver of cancer, we hypothesized that anakinra might...
4.
Vettermann F, Suchorska B, Unterrainer M, Nelwan D, Forbrig R, Ruf V, et al.
Eur J Nucl Med Mol Imaging
. 2019 Aug;
46(12):2581-2589.
PMID: 31410540
Purpose: According to the updated WHO classification of gliomas with its emphasis on molecular parameters, tumours with an IDH-wildtype status have a dismal prognosis. To ensure timely adjustment of treatment,...
5.
Thon N, Tonn J, Kreth F
Onco Targets Ther
. 2019 Mar;
12:1497-1508.
PMID: 30863116
Over the last decade, advances in molecular and imaging-based biomarkers have induced a more versatile diagnostic classification and prognostic evaluation of glioma patients. This, in combination with a growing therapeutic...
6.
Thorsteinsdottir J, Vollmar C, Tonn J, Kreth F, Noachtar S, Peraud A
J Neurol
. 2019 Feb;
266(4):910-920.
PMID: 30701313
Background: Refined localization of the epileptogenic zone (EZ) in patients with pharmacoresistant focal epilepsy proceeding to resective surgery might improve postoperative outcome. We here report seizure outcome after stereo EEG...
7.
Forbrig R, Geyer L, Stahl R, Thorsteinsdottir J, Schichor C, Kreth F, et al.
Eur Radiol
. 2019 Jan;
29(6):2859-2867.
PMID: 30635759
Objectives: Intraoperative CT (iCT) angiography of the brain with stereotactic frames is an integral part of navigated neurosurgery. Validated data regarding radiation dose and image quality in these special examinations...
8.
Lenski M, Biczok A, Tonn J, Kreth F
World Neurosurg
. 2018 Dec;
123:e670-e677.
PMID: 30576829
Introduction: Treatment of symptomatic intracranial cysts remains a controversial issue. We present a risk/benefit profile of a minimally invasive, not yet described, stereotactic internal shunt implantation technique. The provided data...
9.
Suchorska B, Schuller U, Biczok A, Lenski M, Albert N, Giese A, et al.
Eur J Cancer
. 2018 Dec;
107:15-27.
PMID: 30529899
Background: Mutation of the isocitrate dehydrogenase (IDH) gene and co-deletion on chromosome 1p/19q is becoming increasingly relevant for the evaluation of clinical outcome in glioma. Among the imaging parameters, contrast...
10.
Hubner M, Hinske C, Effinger D, Wu T, Thon N, Kreth F, et al.
Cancers (Basel)
. 2018 Oct;
10(11).
PMID: 30366472
Background: The second intron of Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4), an important hub in the pro-invasive MAPK pathway, harbors miR-744. There is accumulating evidence that intronic micro-RNAs (miRNAs) are...